Skip to content

Clinical trials

Phase 1 Leukemia, Mast-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Mast-Cell Phase: Phase 1 Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20111
20151
20161
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation2
National Cancer Institute (NCI)2
Deciphera Pharmaceuticals, LLC1
Northwestern University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Mast-Cell6
Burkitt Lymphoma3
Intraocular Lymphoma3
Leukemia, Biphenotypic, Acute3
Leukemia, Hairy Cell3
Leukemia, Large Granular Lymphocytic3
Leukemia, Lymphocytic, Chronic, B-Cell3
Leukemia, Myeloid, Accelerated Phase3
Leukemia, Myeloid, Acute3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative3

Trials

Showing 26 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.